The social determinants of national tuberculosis incidence rates in 116 countries: a longitudinal ecological study between 2005-2015
- PMID: 36793018
- PMCID: PMC9930041
- DOI: 10.1186/s12889-023-15213-w
The social determinants of national tuberculosis incidence rates in 116 countries: a longitudinal ecological study between 2005-2015
Abstract
Background: Accelerating declines in tuberculosis (TB) incidence is paramount for achieving global goals set for 2030 by the Sustainable Development Goals and the End TB Strategy. The aim of this study was to identify key country-level social determinants of national TB incidence trends.
Methods: This longitudinal ecological study used country-level data extracted from online databases from the period 2005-2015. We used multivariable Poisson regression models allowing for distinct within- and between-country effects to estimate associations between national TB incidence rates and 13 social determinants of health. The analysis was stratified by country income status.
Results: The study sample included 48 low- and lower-middle-income countries (LLMICs) and 68 high- and upper-middle income countries (HUMICs), with a total of 528 and 748 observations between 2005-2015, respectively. National TB incidence rates declined in 108/116 countries between 2005-2015, with an average drop of 12.95% in LLMICs and 14.09% in HUMICs. Between LLMICs, higher Human Development Index (HDI), social protection spending, TB case detection, and TB treatment success were associated with lower TB incidence. Higher prevalence of HIV/AIDS was associated with higher TB incidence. Within LLMICs, increases in HDI over time were associated with lower TB incidence rates. Between HUMICs, higher HDI, health spending, and diabetes prevalence were associated with lower TB incidence, whereas higher prevalence of HIV/AIDS and alcohol-use were associated with higher TB incidence. Within HUMICs, increases in HIV/AIDS and diabetes prevalence over time were associated with higher TB incidence.
Conclusions: In LLMICs, TB incidence rates remain highest in countries with low human development, social protection spending and TB programme performance, and high rates of HIV/AIDS. Strengthening human development is likely to accelerate declines in TB incidence. In HUMICs, TB incidence rates remain highest in countries with low human development, health spending and diabetes prevalence, and high rates of HIV/AIDS and alcohol use. Here, slowing rising rates of HIV/AIDS and diabetes is likely to accelerate declines in TB incidence.
Keywords: Ecological; End tuberculosis; Multi-country; Social determinants of health; Sustainable development goals; Tuberculosis incidence.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Spatial distribution and determinants of tuberculosis incidence in Mozambique: A nationwide Bayesian disease mapping study.Spat Spatiotemporal Epidemiol. 2024 Feb;48:100632. doi: 10.1016/j.sste.2023.100632. Epub 2023 Dec 12. Spat Spatiotemporal Epidemiol. 2024. PMID: 38355255
-
Clustering and modeling joint-trajectories of HIV/AIDS and tuberculosis mortality rates using bayesian multi-process latent growth model: A global study from 1990 to 2021.BMC Infect Dis. 2025 Mar 10;25(1):330. doi: 10.1186/s12879-025-10715-x. BMC Infect Dis. 2025. PMID: 40065233 Free PMC article.
-
Tuberculosis in sub-Saharan Africa: a regional assessment of the impact of the human immunodeficiency virus and National Tuberculosis Control Program quality.Tuber Lung Dis. 1996 Jun;77(3):220-5. doi: 10.1016/s0962-8479(96)90004-0. Tuber Lung Dis. 1996. PMID: 8758104
-
Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis.PLoS Med. 2021 Sep 14;18(9):e1003712. doi: 10.1371/journal.pmed.1003712. eCollection 2021 Sep. PLoS Med. 2021. PMID: 34520463 Free PMC article.
-
The growing burden of tuberculosis: global trends and interactions with the HIV epidemic.Arch Intern Med. 2003 May 12;163(9):1009-21. doi: 10.1001/archinte.163.9.1009. Arch Intern Med. 2003. PMID: 12742798 Review.
Cited by
-
Pulmonary tuberculosis epidemiology and genetics in Kazakhstan.Front Public Health. 2024 Apr 19;12:1340673. doi: 10.3389/fpubh.2024.1340673. eCollection 2024. Front Public Health. 2024. PMID: 38706548 Free PMC article.
-
The next generation of drug resistant tuberculosis drug design.Future Med Chem. 2025 Feb;17(4):385-387. doi: 10.1080/17568919.2025.2453406. Epub 2025 Jan 15. Future Med Chem. 2025. PMID: 39814693 No abstract available.
-
The social determinants of tuberculosis: a case-control study characterising pathways to equitable intervention in Peru.Infect Dis Poverty. 2025 Jun 20;14(1):53. doi: 10.1186/s40249-025-01324-6. Infect Dis Poverty. 2025. PMID: 40537847 Free PMC article.
-
Tuberculosis treatment failure: what are the risk factors? A comprehensive literature review.Multidiscip Respir Med. 2025 Jul 4;20(1):1030. doi: 10.5826/mrm.2025.1030. Multidiscip Respir Med. 2025. PMID: 40622307 Free PMC article.
-
Spatial clusters of risk and cartography of care for drug-resistant tuberculosis.Rev Saude Publica. 2025 Jun 30;59:e11. doi: 10.11606/s1518-8787.2025059006489. eCollection 2025. Rev Saude Publica. 2025. PMID: 40608609 Free PMC article.
References
-
- World Health Organization. Global Tuberculosis Report 2022 [Internet]. Geneva: World Health Organization, 20. Available from: https://apps.who.int/iris/rest/bitstreams/1474924/retrieve. Cited on 16.01.2023
-
- World Health Organization . The End TB Strategy. Geneva: World Health Organization; 2018.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical